Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 16 of 18
A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia
NCT00965601
The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.
NCT00749736
Using Computers to Assist in Parental Smoking Cessation in a Pediatric Setting
NCT01334216
GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)
NCT00681655
Breathe for Hot Flashes Randomized Controlled Trial
NCT00819182
Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer
NCT00656669
Testing New Method of Analyzing MR Images
NCT00630318
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care
NCT00759252
A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients
NCT00619892
Interactive Computer Program or Brochure in Increasing Colorectal Cancer Screening Among African Americans
NCT00672828
The Study of Ocular Hemodynamics With Glaucoma Progression
NCT01145911
Mobile Communication Technology for Adolescents With Diabetes
NCT00605839
Exercise-based Motivational Interviewing for Fibromyalgia
NCT00573612
Investigation of the Cylex® ImmuKnow® Assay
NCT00569842
A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy
NCT00597181
Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes
NCT00553917
Universal Screening for Maternal Depression With the CHICA System
NCT01238614
Universal Screening for Tuberculosis and Anemia With the CHICA System
NCT01322841
In-Vivo Activated T-Cell Depletion to Prevent GVHD
NCT00594308
Safety Study of Gleevec® in Children With Pulmonary Hypertension
NCT00583115
Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices
NCT01208987
Breast Cancer Screening Via Computer V. Phone
NCT00287040
Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
NCT00532480
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
NCT00726934
Intradialytic Drug Removal by Short-daily Hemodialysis
NCT00596167
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
NCT00545181
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
NCT00596622
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
NCT00569179
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
NCT00477386
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
NCT00577122
Metabolomics-Based Detection of Colorectal Cancer
NCT00507598
Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics
NCT00668395
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT
NCT00477542
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL
NCT00477945
A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
NCT00393497
Endoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective
NCT00880633
A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
NCT00420459
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study
NCT00578279
Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole
NCT00668902
Healozone Study to Evaluate the Safety and Efficacy of the Use of Ozone for Management of Dental Caries
NCT00495495
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
NCT00586313
Assessment of Lung Structure and Function of Infants Born Prematurely
NCT00422305
A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
NCT02563834
Storage of Bile From Routine Procedures to Study Risk Factors
NCT00414843
Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates
NCT00577083
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
NCT00428246
HIV Testing & Womens Attitudes on HIV Vaccine Trials
NCT00771537
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
NCT00393861
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.